Akers Biosciences Forms Diagnostic JV in China with Hainan Savy

Akers Biosciences, a New Jersey diagnostics company, signed a joint venture with Hainan Savy Investment Management Ltd. to develop Akers' rapid diagnostic screening and testing products in China. Thomas Knox, Aker's Non-executive Co-Chairman is also a partner in the JV. Akers currently makes 12 tests on six separate technology platforms. It plans to develop and market the majority of its tests in China, emphasizing products for diabetes, cardiac and infectious diseases. More details.... Stock Symbols: (NSDQ: AKER; LSE: AKR) Share this with colleagues: // //